Page last updated: 2024-10-29

ifosfamide and Rheumatoid Arthritis

ifosfamide has been researched along with Rheumatoid Arthritis in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Patients having rheumatoid arthritis (RA) treated with methotrexate (MTX) are at an increased risk of developing lymphoproliferative disorder (LPD)."3.81Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs. ( Fukayama, M; Koda, K; Tajima, S; Takanashi, Y, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tajima, S1
Takanashi, Y1
Koda, K1
Fukayama, M1
Ströbel, G1
Dreher, R1

Other Studies

2 other studies available for ifosfamide and Rheumatoid Arthritis

ArticleYear
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
    Pathology international, 2015, Volume: 65, Issue:12

    Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Vi

2015
[Number of T and B-lymphocytes in the peripheral blood in rheumatoid arthritis relative to the disease activity, the serum immunoglobulin level and the drug therapy].
    Verhandlungen der Deutschen Gesellschaft fur Rheumatologie, 1978, Volume: 5

    Topics: Arthritis, Rheumatoid; Azathioprine; B-Lymphocytes; Cell Count; Gold; Humans; Ifosfamide; Immunoglob

1978